The Hepatic Artery, Portal Venous System and Portal Hypertension: The Hepatic Veins and Liver in Circulatory Failure

Sherlock's Diseases of the Liver and Biliary System, 12th Edition

Volumn , Issue , 2011, Pages 152-209

  Burroughs, Andrew K ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Constrictive pericarditis; Gastro oesophageal varices; Heart failure; Hepatic artery aneurysms; Hepatic artery thrombosis; Hepatic venous outflow obstruction; Hepatic venous pressure gradient; Hypoxic hepatitis; Non cirrhotic portal hypertension; Non selective beta blocker; Portal hypertensive colonopathy; Portal hypertensive gastropathy; Portal pressure; Portal vein thrombosis; Splanchnic venous thrombosis; Splenomegaly; Surgical shunt; Transjugular intrahepatic stent shunt; Variceal bleeding; Variceal ligation

Indexed keywords

EID: 84867886203     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341294.ch9     Document Type: Chapter

References (287)

1. Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann. Surg. 1994; 220: 50-52.
2. Yamamoto K, Sherman I, Phillips MJ et al. Three-dimensional observations of the hepatic arterial terminations in rat, hamster and human liver by scanning electron microscopy of micro vascular casts. Hepatology 1985; 5: 452-456.
3. Sherlock S. The syndrome of disappearing intrahepatic bile ducts. Lancet 1987; ii: 493-496.
4. Barquist ES, Goldstein N, Zinner MJ. Polyarteritis nodosa presenting as a biliary stricture. Surgery 1991; 109: 16-19.
5. Tygstrup N, Winkler K, Mellengaard K et al. Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery. J. Clin. Invest. 1962; 41: 447-454.
6. Lautt WW, Greenaway CV. Conceptual review of the hepatic vascular bed. Hepatology 1987; 7: 952-963.
7. Legmann P, Costes V, Tudoret L. Hepatic artery thrombosis after liver transplantation: diagnosis with spiral CT. Am. J. Roentgenol. 1995; 164: 97-101.
8. Soyer P, Bluemke DA, Choit MA et al. Variations in the intrahepatic portions of the hepatic and portal veins: findings on helical CT scans during arterial portography. Am. J. Roentgenol. 1995; 164: 103-108.
9. Kronthal AJ, Fishman EK, Kuhlman JE et al. Hepatic infarction in pre-eclampsia. Radiology 1990; 177: 726-728.
10. Khoury G, Tobi M, Oren M et al. Massive hepatic infarction in systemic lupus erythematosus. Dig. Dis. Sci. 1990; 35: 1557-1560.
11. Bacha EA, Stieber AC, Galloway JR et al. Non-biliary complication of laparoscopic cholecystectomy. Lancet 1994; 344: 896-897.
12. Simons RK, Sinanan MN, Coldwell DM. Gangrenous cholecystitis as a complication of hepatic artery embolization: case report. Surgery 1992; 112: 106-110.
13. Ludwig J, Batts KP, MacCarthy RL. Ischemic cholangitis in hepatic allografts. Mayo Clin. Proc. 1992; 67: 519-526.
14. Gunsar F, Rolando N, Pastacaldi S et al. Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl. 2003; 9: 605-11.
15. Croce MA, Fabian TC, Spiers JP et al. Traumatic hepatic artery pseudoaneurysm with haemobilia. Am. J. Surg. 1994; 168: 235-238.
16. Zachary K, Geier S, Pellecchia D et al. Jaundice secondary to hepatic artery aneurysm: radiological appearance and clinical features. Am. J. Gastroenterol. 1986; 81: 295-298.
17. Kibbler CC, Cohen DL, Cruickshank JK et al. Use of CT scanning in the diagnosis and management of hepatic artery aneurysm. Gut 1985; 26: 752-756.
18. Falkoff GE, Taylor KJW, Morse S. Hepatic artery pseudo-aneurysm: diagnosis with real-time and pulsed Doppler US. Radiology 1986; 158: 55-56.
19. Douglass BE, Baggenstoss AH, Hollinshead WH. Variations in the portal systems of veins. Proc. Mayo Clin. 1950; 25: 26.
20. McIndoe AH. Vascular lesions of portal cirrhosis. Arch. Path. 1928; 5: 23.
21. Kimura K, Ohto M, Matsutani S et al. Relative frequencies of portosystemic pathways and renal shunt formation through the ' posterior'gastric vein: portographic study in 460 patients. Hepatology 1990; 12: 725-728.
22. Park JH, Cha SH, Han JK et al. Intrahepatic portosystemic venous shunt. Am. J. Roentgenol. 1990; 155: 527-528.
23. Manenti F, Williams R. Injection of the splenic vasculature in portal hypertension. Gut 1966; 7: 175-180.
24. Kitano S, Terblanche J, Kahn D et al. Venous anatomy of the lower oesophagus in portal hypertension: practical implications. Br. J. Surg. 1986; 73: 525-531.
25. Vianna A, Hayes PC, Moscoso G et al. Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology 1987; 93: 876-889.
26. McCormack TT, Rose JD, Smith PM et al. Perforating veins and blood flow in oesophageal varices. Lancet 1983; ii: 1442-1444.
27. Dan SJ, Train JS, Cohen BA et al. Common bile duct varices: cholangiographic demonstration of a hazardous porto-systemic communication. Am. J. Gastroenterol. 1983; 78: 42-3.
28. Gudjonsson H, Zeiler D, Gamelli R et al. Colonic varices. Report of an unusual case diagnosed by radionuclide scanning, with review of the literature. Gastroenterology 1986; 91: 1543-1547.
29. Weinshel E, Chen W, Falkenstein DB et al. Hemorrhoids or rectal varices: defining the cause of massive rectal hemorrhage in patients with portal hypertension. Gastroenterology 1986; 90: 744-747.
30. Viggiano TR, Gostout CJ. Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features. Am. J. Gastroenterol. 1992; 87: 944-954.
31. Panés J, Piqué JM, Bordas JM et al. Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy. Hepatology 1994; 19: 55-60.
32. Payen J-L, Calès P, Voigt J-J et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology 1995; 108: 138-144.
33. Spahr L, Villeneuve J-P, DuFresne MP et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999; 44: 739-742.
34. Nagral AS, Joshi AS, Bhatia SJ et al. Congestive jejunopathy in portal hypertension. Gut 1993; 34: 694-697.
35. Scandalis N, Archimandritis A, Kastanas K et al. Colonic findings in cirrhotics with portal hypertension. A prospecthetive colonoscopic and histological study. J. Clin. Gastroenterol. 1994; 18: 325-328.
36. Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J. Hepatol. 2007; 46: 927-934.
37. Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J. Hepatol. 1985; 1: 325-337.
38. Blendis LM, Orrego H, Crossley IR et al. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and non-cirrhotic liver disease. Hepatology 1982; 2: 539-546.
39. Grossman HJ, Gorssman VL, Bhathal PS. The effect of hepatocyte enlargement on the haemodynamic characteristics of the isolated perfused rat liver preparation. Hepatology 1998; 27: 446-451.
40. Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin and nitric oxide. Hepatology 1997; 25: 2-5.
41. Sogni P, Moreau R, Gadano A et al. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J. Hepatol. 1995; 23: 218-224.
42. Gerbes AL, Bilzer M, Gulberg V. Role of endothelins. Digestion 1998; 59: 410-412.
43. Wheatley AM, Zhang X-Y. Intrahepatic modulation of portal pressure and its role in portal hypertension. Digestion 1998; 59: 424-428.
44. Fernandez M, Mejias M, Garcia-Pras E et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet derived growth factor blockade in rats. Hepatology 2007; 46: 1208-1217.
45. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20: 1359-1363.
46. Oberti F, Sogni P, Cailmail S et al. Role of prostacyclin in haemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology 1993; 18: 621-627.
47. Pak J-M, Lee SS. Glucagon in portal hypertension. J. Hepatol. 1994; 20: 825-832.
48. Cruveilhier J. A natomie pathologique du corps humain, vol. I. XVI livr. pl. vi, Maladies du Veines. Paris: J.B. Baillière, 1829-1835.
49. Baumgarten P von. Über völlstandiges Offenbleiben der Vena umbilicalis: zugleichein Beitrag zur Frage des Morbus Bantii. Arb. Path. Anat. Inst. Tübingen 1907; 6: 93.
50. Bisseru B, Patel JS. Cruveilhier-Baumgarten disease. Gut 1989; 30: 136-137.
51. Hosking SW, Smart HL, Johnson AG et al. Anorectal varices, haemorrhoids and portal hypertension. Lancet 1989; i: 349-352.
52. Ayuso C, Luburich P, Vilana R et al. Calcifications in the portal venous system: comparison of plain films, sonography, and CT. Am. J. Roentgenol. 1992; 159: 321-323.
53. Dennis MA, Pretorius D, Manco-Johnson ML et al. CT detection of portal venous gas associated with suppurative cholangitis and cholecystitis. Am. J. Roentgenol. 1985; 145: 1017-1018.
54. North Italian Endoscopic Club for Study and Treatment of Esophageal Varices. Prediction of the first variceal haemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicentre study. N. Engl. J. Med. 1988; 319: 983-989.
55. Calès P, Zabotto B, Meskens C et al. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology 1990; 98: 156-162.
56. Spina GP, Arcidiacono R, Bosch J et al. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, 19 September 1992. J. Hepatol. 1994; 21: 461-467.
57. D'Amico G, Montalbano L, Traina M et al. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990; 99: 1558-1564.
58. de Franchis R, Risen GM, Laine L et al. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology 2008; 47: 1595-1603.
59. Giannini EG, Zaman A, Kreil A et al. Platelet count/spleen diameter ratio for the non-invasive diagnosis of oesophageal varices: results of a multicentre prospective validation study. Am. J. Gastroenterol. 2006; 101: 2511-2519.
60. Ganguly S, Sarin SK, Bhatia V et al. The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology 1995; 21: 1226-1231.
61. Gaiani S, Bolondi L, Li Bassi S et al. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Gastroenterology 1991; 100: 160-167.
62. Kudo M, Tomita S, Tochio H et al. Intrahepatic portosystemic venous shunt: diagnosis by colour Doppler imaging. Am. J. Gastroenterol. 1993; 88: 723-729.
63. Redvanly RD, Chezmar JL. CT arterial portography: technique, indications and applications. Clin. Radiol. 1997; 52: 256-268.
64. Taylor CR. Computed tomography in the evaluation of the portal venous system. J. Clin. Gastroenterol. 1992; 14: 167-172.
65. Finn JP, Kane RA, Edelman RR et al. Imaging of portal venous system in patients with cirrhosis: MR angiography vs. duplex Doppler sonography. Am. J. Roentgenol. 1993; 161: 989-994.
66. Atkinson M, Sherlock S. Intrasplenic pressure as an index of the portal venous pressure. Lancet 1954; i: 1325-1327.
67. Groszmann RJ, Glickman M, Blei AT et al. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology 1979; 76: 253-258.
68. Vlachogiannakos J, Patch D, Watkinson A et al. Carbon-dioxide portography: an expanding role? Lancet 2000; 355: 987-988.
69. Burroughs AK, Thalheimer U. Hepatic venous pressure gradient in 2010: optimal measurement is key. Hepatology 2010; 51: 1894-1896.
70. Thalheimer U, Leandro G, Samonakis DN et al. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhosis patients. Dig. Liv. Dis. 2005; 37: 601-608.
71. Ripoll C, Groszmann RJ, Garcia-Tsao G et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481-488.
72. Senzolo M, Burra P, Cholongitas E et al. The transjugular route: the key hole to the liver world. Dig. Liver Dis. 2007; 39: 105-116.
73. Armonis A, Patch D, Burroughs A. Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis. Hepatology 1997; 25: 245-248.
74. Burroughs AK, Triantos CK. Predicting failure to control bleeding and mortality in acute variceal bleeding. J. Hepatol. 2008; 48: 185-188.
75. Triantos CK, Nikolopoulou V, Burroughs AK. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis. Aliment. Pharmacol. Therap. 2008; 28: 943-952.
76. Nevens F, Bustami R, Scheys I et al. Variceal pressure is a factor predicting the risk of a first variceal bleeding. A prospective cohort study in cirrhotic patients. Hepatology 1998; 27: 15-19.
77. Hou MC, Lin HC, Kou BIT et al. Sequential variceal pressure measurement by endoscopic needle puncture during maintenance sclerotherapy: the correlation between variceal pressure and variceal rebleeding. J. Hepatol. 1998; 29: 772-778.
78. Gertsch P, Fischer G, Kleber G et al. Manometry of esophageal varices: comparison of an endoscopic balloon technique with needle puncture. Gastroenterology 1993; 105: 1159-1166.
79. Bradley SE, Ingelfinger FJ, Bradley GP et al. Estimation of hepatic blood flow in man. J. Clin. Invest. 1945; 24: 890-897.
80. Caesar J, Shaldon S, Chiandussi L et al. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin. Sci. 1961; 21: 43-57.
81. Bosch J, Groszmann RJ. Measurement of azygous venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 1984; 4: 424-429.
82. Webster GJ, Burroughs AK, Riordan SM. Portal vein thrombosis-new insigts into aetiology and management. Aliment. Pharmacol. Therap. 2005; 21: 1-9.
83. Thompson EN, Sherlock S. The aetiology of portal vein thrombosis with particular reference to the role of infection and exchange transfusion. Q. J. Med. 1964; 33: 465-480.
84. Dubuisson C, Boyer-Neumann C, Wolf M et al. Protein C, protein S and antithrombin III in children with portal vein obstruction. J. Hepatol. 1997; 27: 132-135.
85. Valla D, Casadevall N, Huisse MG et al. Etiology of portal thrombosis in adults. Gastroenterology 1988; 94: 1063-1069.
86. Wanless IR, Peterson P, Das A et al. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology 1990; 12: 1166-1174.
87. Bernades P, Baetz A, Lévy P et al. Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig. Dis. Sci. 1992; 37: 340-346.
88. Morse SS, Taylor KJW, Strauss EB et al. Congenital absence of the portal vein in oculoauriculo-vertebral dysplasia (Goldenhar syndrome). Pediatr. Radiol. 1986; 16: 437-439.
89. Odièvre M, Pigé G, Alagille D. Congenital abnormalities associated with extrahepatic portal hypertension. Arch. Dis. Child. 1977; 52: 383-385.
90. Tsochatzis EA, Senzolo M, Germani G et al. Systemic review:portal vein thrombosis in cirrhosis. Aliment. Pharmacol. Therap. 2010; 31: 366-374.
91. Capron JP, LeMay JL, Muir JF et al. Portal vein thrombosis and fatal pulmonary thromboembolism associated with oral contraceptive treatment. J. Clin. Gastroenterol. 1981; 3: 295-298.
92. Bayraktar Y, Balkanci F, Kansu E et al. Cavernous transformation of the portal vein: a common manifestation of Behçet's disease. Am. J. Gastroenterol. 1995; 90: 1476-1479.
93. Sarin SK, Bansal A, Sasan S, Nigram A. Portal vein obstruction in children leads to growth retardation. Hepatology 1992; 15: 229-233.
94. Thompson EN, Williams R, Sherlock S. Liver function in extra-hepatic portal hypertension. Lancet 1964; ii: 1352-1356.
95. Senzolo M, Cholongitas E, Tibballs J et al. Relief of biliary obstruction due to portal vein cavernoma using a transjugular intrahepatic portosystemic shunt (TIPS) without need for long term stenting. Endoscopy 2006; 38: 760.
96. Konno K, Ishida H, Uno A et al. Cavernous transformation of the portal vein (CTPV): role of colour Doppler sonography in the diagnosis. Eur. J. Ultrasound 1996; 3: 231-240.
97. Parvey HR, Raval B, Sandler CM. Portal vein thrombosis: imaging findings. Am. J. Roentgenol. 1994; 162: 77-81.
98. Webb L, Smith-Laing G, Lake-Bakaar G et al. Pancreatic hypofunction in extrahepatic portal venous obstruction. Gut 1980; 21: 227-231.
99. Plessier A, Darwish-Murad S, Hernandez-Guerra M et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multi-centre follow up study. Hepatology 2010; 51: 210-218.
100. De Ville de Goyet J, Alberti D, Clapuyt P et al. Direct by passing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revscularisation and treatment of extra hepatic portal hypetension. J. Surg. 1998; 33: 597-601.
101. Senzolo M, Tibballs J, Cholangitas E et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and witout cavernous transformation. Aliment. Pharmacol. Therap. 2006; 23: 767-775.
102. Loftus JP, Nagorney DM, Ilstrup D et al. Sinistral portal hypertension. Splenectomy or expectant management. Ann. Surg. 1993; 217: 35-40.
103. Shields SJ, Byse BH, Grace ND. Arterioportal fistula: a role for pre-TIPSS arteriography and hepatic venous pressure measurements. Am. J. Gastroenterol. 1992; 87: 1828-1832.
104. Chagnon SF, Vallee CA, Barge J et al. Aneurysmal portal hepatic venous fistula: report of two cases. Radiology 1986; 159: 693-695.
105. Dubois A, Dauzat M, Pignodel C et al. Portal hypertension in lymphoproliferative and myeloproliferative disorders: haemodynamic and histological correlations. Hepatology 1993; 17: 246-250.
106. Ludwig J, Hashimoto E, Obata H et al. Idiopathic portal hypertension. Hepatology 1993; 17: 1157-1162.
107. Oikawa H, Masuda T, Sato S-I et al. Changes in lymph vessels and portal veins in the portal tract of patients with idiopathic portal hypertension; a morphometric study. Hepatology 1998; 27: 1607-1610.
108. Sarin SK. Progress report. Non-cirrhotic portal fibrosis. Gut 1989; 30: 406-415.
109. Mikkelsen WP. Extrahepatic portal hypertension in children. Am. J. Surg. 1966; 111: 333-340.
110. Kingham JG, Levinson DA, Stansfeld AG et al. Non-cirrhotic intrahepatic portal hypertension. A long-term follow-up study. Q. J. Med. 1981; 50: 259-268.
111. Popper H, Elias H, Petty DE. Vascular pattern of the cirrhotic liver. Am. J. Clin. Path. 1952; 22: 717-729.
112. Shaldon S, Chiandussi L, Guevara L et al. The measurement of hepatic blood flow and intrahepatic shunted blood flow by colloid heat denatured human serum albumin labelled with I131. J. Clin. Invest. 1961; 40: 1346-1354.
113. Kelty RH, Baggenstoss AH, Butt HR. The relation of the regenerated liver nodule to the vascular bed in cirrhosis. Gastroenterology 1950; 15: 285-295.
114. Groszmann RJ, Garcia-Tsao G, Bosch J et al. Beta-blockers to prevent gastro-oesophageal varices in patients with cirrhosis. N. Engl. J. Med. 2005; 353: 2254-2261.
115. Merli M, Nicolini G, Angeloni S et al. Incidence and natural history of small oesophageal varices in cirrhotic patients. J. Hepatol. 2003; 38: 266-272.
116. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999; 353: 1102.
117. Lebrec D, de Fleury P, Rueff B. Portal hypertension, size of esophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139-1144.
118. Kleber G, Sauerbruch T, Ansari H et al. Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology 1991; 100: 1332-1337.
119. Schmassmann A, Zuber M, Livers M et al. Recurrent bleeding after variceal haemorrhage: predictive value of portal venous duplex sonography. Am. J. Roentgenol. 1993; 160: 41-47.
120. Burroughs AK, Patch D. Primary prevention of bleeding from esophageal varices. N. Engl. J. Med. 1999; 340: 1033-1035.
121. Groszmann RJ, Bosch J, Grace ND et al. Hemodynamic events in a prospective randomized trial of propranolol vs placebo in the prevent of a first variceal hemorrhage. Gastroenterology 1990; 99: 1401-1407.
122. Mastai R, Bosch J, Bruix J et al. Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology 1989; 10: 269-272.
123. Garcia-Tsao G, Grace ND, Groszmann RJ et al. Short-term effects of propranolol on portal venous pressure. Hepatology 1986; 6: 101-106.
124. Pagliaro L, D'Amico G, Sorensen TIA et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann. Intern. Med. 1992; 117: 59-70.
125. Gludd LL, Klingenberg S, Nikolova D et al. Banding ligation versus beta-blockers as primary prophylaxis in oesophageal varices: a systematic review of randomized trials. Am. J. Gastroenterol. 2007; 102: 2842-2848.
126. Tsochatzis E, Triantos C, Burroughs AK. Non-selective beta-bockers and prevention of first variceal bleeding. J. Hepatol. 2010; 52: 946-948.
127. Tripathi D, Ferguson JW, Kochar N et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of first variceal bleed. Hepatology 2009; 50: 825-833.
128. Tsochatzis EA, Christos CK, Burroughs AK. Variceal bleeding: carvedilol the best beta-blocker for primary prophylaxis? Nat. Rev. Gastroenterol. Hepatol. 2009; 6: 992-994.
129. Groszmann RJ. Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly. Gastroenterology 1997; 113: 1794-1797.
130. Burroughs AK, Planas R, Svoboda P. Optimizing care of upper gastrointestinal bleeding in cirrhotic patients. Scand. J. Gastroenterol. 1998; 226: 14-24.
131. Siringo S, McCormick PA, Mistry PA et al. Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest. Endoscopy 1991; 37: 51-55.
132. McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over 4 decades. Gut 2001; 49: 682-685.
133. Ben-Ari Z, Cardin F, McCormick PA et al. A predictive model for failure to control bleeding during acute variceal haemorrahge. J. Hepatol. 1999; 31: 443-450.
134. Vlachogiannakos J, Carpenter J, Goulis J et al. Variceal bleeding in primary biliary cirrhosis patients: a subgroup with improved prognosis and a model to predict survival after first bleeding. Eur. J. Gastroenterol. Hepatol. 2009; 21: 701-707.
135. Bernard B, Grange J-D, Khac EN et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding; a meta-analysis. Hepatology 1999; 29: 1655-1661.
136. Hou MC, Lin HC, Liu TT et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal haemorrhage: a randomized trial. Hepatology 2004; 39: 746-753.
137. Jun CH, Park CH, Lee WS et al. Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal haemorrhage. A prospective randomized study. J. Korean Med. Sci. 2006; 21: 883-890.
138. de Franchis R, Baveno V Faculty. Revising consensus in portal hypertension:report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 2010; 53: 762-768.
139. Kravetz D, Bosch J, Teres J et al. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal haemorrhage. Hepatology 1984; 4: 442-446.
140. Gotzsche PC, Hrobjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst. Rev. 2008; 3: CD000193.
141. Wright G, Lewis H, Hogan B et al. A self expanding metal stent for complicated variceal haemorrhage: experience at a single centre. Gastrointest. Endoscopy 2010; 71: 71-78.
142. Zehetner J, Shamiyeh A, Wayand W, Hubmann R. Results of a new method to stop acute bleeding from oesophageal varices: implantation of self expanding stent. Endoscopy 2008; 22: 2140-2152.
143. Triantos CK, Goulis J, Patch D et al. An evaluation of emergency sclerotherapy of varices in randomized trials: looking at the needle in the eye. Endoscopy 2006; 38: 797-807.
144. Chau TN, Patch D, Chan YW et al. 'Salvage'transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981-987.
145. Monescillo A, Martinex-Langares F, Ruiz del Arbo L et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40: 793-801.
146. Garcia-Pagan JC, Caca K, Bureaueau C et al. E arly use of TIPS in patients with cirrhosis and variceal bleeding. N. Engl. J. Med. 2010; 362: 2370-2379.
147. Tan PC, Hou MC, Lin HC et al. A randomized trial of endoscopic treatment of acute gastric variceal haemorrhage: N butyl-2 cyanoacrylate injection versus band ligation. Hepatology 2006; 43: 690-7 (erratum 2006; 43: 1410).
148. Bureau C, Garcia-Pagan JC, Otal P et al. Improved clinical outcome using polytetrafluoroethylene coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126: 469-475.
149. Rössle M, Haag K, Ochs A et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N. Engl. J. Med. 1994; 330: 165-171.
150. Ducoin H, El-Khoury J, Rousseau H et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology 1997; 25: 1064-1069.
151. Sanyal AJ, Contos MJ, Yager D et al. Development of pseudointima and stenosis after transjugular intrahepatic portosystemic shunts; characterization of cell phenotype and function. Hepatology 1998; 28: 22-32.
152. Sanyal A, Freedman AM, Luketic VA et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal haemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111: 138-146.
153. Vangeli M, Patch D, Terreni N et al. Bleeding ectopic varices-treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation. J. Hepatol. 2004; 41: 560-566.
154. Sanyal AJ, Freedman AM, Purdum PP et al. The haematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996; 23: 32-39.
155. Rouillard SS, Bass NM, Roberts JP et al. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann. Intern. Med. 1998; 128: 374-377.
156. Jabbour N, Zajko A, Orons P et al. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig. Dis. Sci. 1998; 43: 2459-2462.
157. Lind CD, Malish TW, Chong WK et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994; 106: 1277-1283.
158. LaBerge JM, Somberg KA, Lake JR et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108: 1143-1151.
159. Selim N, Fendley MJ, Boyer TD et al. Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child's A or B cirrhosis. Ann. Surg. 1998; 227: 600-603.
160. Orloff MJ, Bell RH Jr, Orloff MS et al. Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotic patients with bleeding varices. Hepatology 1994; 20: 863-872.
161. Burroughs AK, Hamilton G, Philips A et al. A comparison of sclerotherapy with staple transaction of the oesophagus for the emergency control of bleeding from oesophageal varices. N. Engl. J. Med. 1989; 321: 857-862.
162. McCormick PA, Kaye GL, Greenslade L et al. Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy. Hepatology 1992; 15: 403-406.
163. Gonzalez R, Zamora J, Gomez-Camero J et al. Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann. Intern. Med. 2008; 149: 109-122.
164. Perez-Ayuso RM, Pique JP, Bosch J et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991; 337: 1431-1434.
165. Eck NV. On the question of ligature of the portal vein (trans. title). Voyenno Med. J. (St Petersburg) 1877; 130: Sect. 2.1.
166. Dowling JB. Ten years'experience with mesocaval grafts. Surg. Gynecol. Obstet. 1979; 149: 518-522.
167. Millikan WJ, Warren WD, Henderson JM et al. The Emory prospective randomized trial selective vs non-selective shunt to control variceal bleeding. Ten year follow up. Ann. Surg. 1985; 201: 712-722.
168. Spina GP, Henderson JM, Rikkers LF et al. Distal splenorenal sunt ersus endoscopic sclerotherapy in prevention of variceal rebleeding. A meta analysis of 4 randomized clinical trials. J. Hepatol. 1992; 16: 338-345.
169. Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scan. J. Gastroenterol. 2002; 37: 249-252.
170. Zacks SL, Sandler RS, Biddle AK et al. Decision analysis of transjugular intrahepatic portosystemic shunt vs. distal splenorenal shunt for portal hypertension. Hepatology 1999; 29: 1399-1405.
171. Sanyal AJ, Freedman AM, Shiffman ML et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20: 46-55.
172. Riggio O, Merli M, Pedretti G et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig. Dis. Sci. 1996; 41: 578-584.
173. Nolte W, Wiltfang J, Schindler C et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric and electroencephalographic investigations. Hepatology 1998; 28: 1215-1225.
174. Guevara M, Gines P, Bandi JC et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28: 416-422.
175. Huonker M, Schumacher YO, Ochs A et al. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999; 44: 743-748.
176. Van der Linden P, Le Moine O, Ghysels M et al. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 1996; 23: 982-987.
177. Ho K-S, Lashner BA, Emond JC et al. Prior esophageal variceal bleeding does not adversely affect survival after orthotopic liver transplantation. Hepatology 1993; 18: 66-72.
178. Ewaga H, Keeffe EB, Dort J et al. Liver transplantation for uncontrollable variceal bleeding. Am. J. Gastroenterol. 1994; 89: 1823-1826.
179. Guerrini GP, Pleguezuelo M, Maimone S et al. Impact of TIPS pre-liver transplantation for the outcome post transplantation. Am. J. Transplant. 2009; 9: 192-200.
180. Navasa M, Feu F, Garcia-Pagán JC et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993; 17: 355-360.
181. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006; 131: 1611-1624.
182. Thalheimer V, Mela M, Patch D, Burroughs AK. Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a core look at the evidence. Gut 2004; 53: 143-148.
183. Villaneuva C, Aracil C, Colomo A et al. Clinical trial: a randomized controlled study on the prevention of variceal rebleeding comparing nadolol and ligation vs hepatic venous pressure gradient guided pharmacological therapy. Aliment. Pharmacol. Therap. 2009; 29: 397-408.
184. Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey-the case for non-selective beta blockers. Gastroenterology 2007; 133: 2029-2036.
185. Lo GH, Cheu WC, Lin CK et al. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology 2008; 48: 580-587.
186. Senzolo M, Cholongitas E, Burra P et al. Beta-blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int. 2009; 29: 1189-1193.
187. Thalheimer U, Triantos CK, Samonakis DN et al. Infection, coagulation and variceal bleeding in cirrhosis. Gut 2005; 54: 556-563.
188. Vorobioff J, Groszmann RJ, Picabea E et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhsis: a 10 year prospective study. Gastroenterology 1996; 111: 701-709.
189. Abraldes JG, Tarantino I, Turnes J et al. Haemodynamic response to pharmacological treatment of portal hypertension and influence on complications of cirrhosis. Hepatology 2003; 37: 902-908.
190. Villaneuva C, Lopez-Balaguer JM, Aracil C et al. Maintenance of haemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J. Hepatol. 2004; 40: 757-765.
191. Abraldes JG, Albillos A, Banares R et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology 2009; 136: 1651-1658.
192. Dodds WJ, Erickson SJ, Taylor AJ et al. Caudate lobe of the liver: anatomy, embryology, and pathology. Am. J. Roentgenol. 1990; 154: 87-93.
193. Bolton C, Barnard WG. The pathological occurrences in the liver in experimental venous stagnation. J. Path. Bact. 1931; 34: 701.
194. Senzolo M, Cholangitas E, Patch D, Burroughs AK. Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat. Clin. Pract. Gastroenterol. Hepatol. 2005; 2: 182-190.
195. Budd G. On Diseases of the Liver, 3rd edn. Philadelphia: Blanchard & Lea, 1857.
196. Chiari H. Ueber die selbständige Phlebitis obliterans der Hauptstämme der Venae hepaticae als Todesurache. Beitr. Path. Anat. 1899; 26: 1.
197. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 2003; 38: 793-803.
198. Denninger MH, Chait Y, Casadevall N et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31: 587-591.
199. Hussein K, Bock O, Kreipe J. Histological and molecular classifications of chronic myeloproliferative disorders in the age of JAK2: persistence of old questions despite new answers. Pathobiology 2007; 74: 72-80.
200. Pomeroy C, Knodell RG, Swaim WR et al. Budd-Chiari syndrome in a patient with the lupus anticoagulant. Gastroenterology 1984; 86: 158-161.
201. Pelletier S, Landi B, Piette J-C et al. Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J. Hepatol. 1994; 21: 76-80.
202. Young ID, Clark RN, Manley PN et al. Response to steroids in Budd-Chiari syndrome caused by idiopathic granulomatous venulitis. Gastroenterology 1988; 94: 503-507.
203. Hoekstra J, Leebeek FW, Plessier A et al. Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings form a cohort study. J. Hepatol. 2009; 51: 696-706.
204. Hoekstra J, Guimaraes AHC, Leebeek FWG et al. Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome. Blood 2010; 115: 388-395.
205. Das M, Carroll SF. Antithrombin III deficiency: an aetiology of Budd-Chiari syndrome. Surgery 1985; 97: 242-246.
206. Janssen HL. Factor V Leiden mutation, prothrombin gene mutation and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case controlled study. Blood 2000; 96: 2369-2368.
207. Salooja N, Perry D. Thromboelastography. Blood Coagul. Fibrinolysis 2001; 12: 327-337.
208. Bayraktar Y, Balkanci F, Bayraktar M et al. Budd-Chiari syndrome: a common complication of Behçet's disease. Am. J. Gastroenterol. 1997; 92: 858-862.
209. Valla D, Le MG, Poynard T et al. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: a case-control study. Gastroenterology 1986; 90: 807-811.
210. Minnema MC. Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. J. Heptol. 2000; 33: 509-512.
211. Khuroo MS, Datta V. Budd-Chiari syndrome following pregnancy. Report of 16 cases with roentgenologic haemodynamia and histological studies of the hepatic outflow tract. Am. J. Med. 1980; 68: 113-121.
212. Balian A, Valla D, Naveau S et al. Post-traumatic membranous obstruction of the inferior vena cava associated with a hypercoagulable state. J. Hepatol. 1998; 28: 723-726.
213. Uddin W, Ramage JK, Portmann B et al. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment. Gut 1995; 36: 142-145.
214. Takayasu K, Muramatsu Y, Moriyama N et al. Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases. Am. J. Gastroenterol. 1994; 88: 249-253.
215. Schluger LK, Cubukcu O, Klion F et al. Unexplained Budd-Chiari syndrome in a young man. Hepatology 1995; 21: 584-588.
216. MacMahon HE, Ball HG III. Leiomyosarcoma of hepatic vein and the Budd-Chiari syndrome. Gastroenterology 1971; 61: 239-243.
217. Schraut WH, Chilcote RR. Metastatic Wilms'tumour causing acute hepatic-vein occlusion (Budd-Chiari syndrome). Gastroenterology 1985; 88: 576-579.
218. Dhillon AP, Burroughs AK, Hudson M et al. Hepatic venular stenosis after orthotopic liver transplantation. Hepatology 1994; 19: 106-111.
219. Kiuchi T. Small for size graft in living donor liver transplantation: how far should we go. Liver Transpl. 2003; 9: 529-S35.
220. Blanshard C, Dodge G, Pasi J et al. Membranous obstruction of the inferior vena cava in a patient with factor V Leiden: evidence for prothrombotic aetiology. J. Hepatol. 1997; 26: 731-735.
221. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis vs. thrombosis of the inferior vena cava at its hepatic portion. Hepatology 1998; 28: 1191-1198.
222. Shrestha SM. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J. Gastroenterol. Hepatol. 1996; 11: 170-179.
223. Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. World J. Gastroenterol. 2008; 14: 278-285.
224. Tanaka M, Wanless IR, Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998; 27: 488-496.
225. Casals-Hatem D, Vilgrain V, Genin P et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted lviers. Hepatology 2003; 37: 510-519.
226. Hadengue A, Poliquin M, Vilgrain V et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994; 106: 1042-1047.
227. Millener P, Grant EG, Rose S et al. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. Am. J. Roentgenol. 1993; 161: 307-312.
228. Mori H, Maeda H, Fukuda T et al. Acute thrombosis of the inferior vena cava and hepatic veins in patients with Budd-Chiari syndrome: CT demonstration. Am. J. Roentgenol. 1989; 153: 987-991.
229. Kane R, Eustace S. Diagnosis of Budd-Chiari syndrome: comparison between sonography and magnetic resonance angiography. Radiology 1995; 195: 117-121.
230. Miller WJ, Federle MP, Straub EH et al. Budd-Chiari syndrome: imaging with pathologic correlation. Abdom. Imaging 1993; 18: 329-335.
231. James C, Ugo V, Le Couedic JP et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1134-1148.
232. Zeitoun G. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999; 30: 84-89.
233. Darwish Murad S, Plessier A, Hernandez-Guerra M et al. Etiology, management and outcome of the Budd-Chiari syndrome. Ann. Intern. Med. 2009; 151: 167-175.
234. Moucari R, Rautou PE, Cazals-Hatem D et al. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 2008; 57: 828-835.
235. Tang TJ. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J. Hepatol. 2001; 35: 338-343.
236. Singh V. Budd-Chiari syndrome: our experience of 71 patients. J. Gastroenterol. Hepatol. 2000; 15: 550-554.
237. Okuda H. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J. Hepatol. 1995; 22: 1-9.
238. Ganguli SC, Ramzan NN, McKusick MA et al. Budd-Chiari syndrome in patients with haematological disease: a therapeutic challenge. Hepatology 1998; 27: 1157-1161.
239. Min AD, Atillasoy EO, Schwartz ME et al. Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl. Surg. 1997; 3: 423-429.
240. Martin LG, Henderson JM, Millikan WJ Jr et al. Angioplasty for long-term treatment of patients with Budd-Chiari syndrome. Am. J. Roentgenol. 1990; 154: 1007-1010.
241. Venbrux AC, Savader SJ, Mitchell SE et al. Interventional management of Budd-Chiari syndrome. Semin. Intervent. Radiol. 1994; 11: 312.
242. Mancuso A, Fung K, Mela M et al. TIPS for acute and chronic Budd-Chiari syndrome: a single centre experience. J. Hepatol. 2003; 38: 751-754.
243. Garcia-Pagan JC, Heydtmann M, Raffia S et al. TIPS for Budd Chiari syndrome: long term results and prognostic factors in 124 patients. Gastroenterology 2008; 135: 808-815.
244. Mancuso A, Watkinson A, Tibbals J et al. Budd Chiari syndrome with portal, splenic and superior mesenteric thrombosis treated with TIPS: who dares wins. Gut 2003: 52: 438.
245. Thompson NP, Miller AD, Hamilton G et al. Emergency rescue hepatic Transplantation following shunt surgery for Budd-Chiari Syndrome. Eur. J. Gastroenterol. 1994; 6: 836-837.
246. Ringe B, Lang H, Oldhafer K-J et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-centre experience with 50 patients. Hepatology 1995; 21: 1337-1344.
247. Panis Y, Belghiti J, Valla D et al. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery 1994; 115: 276-281.
248. Gillams A, Dick R, Platts A et al. Dilitation of the inferior vena cava using an expandable metal stent in Budd-Chiari syndrome. J. Hepatol. 1991; 13: 149-151.
249. Senning A. Transcaval posterocranial resection of the liver as treatment for the Budd-Chirari syndrome. World J. Surg. 1983; 7: 632-640.
250. Mentha G, Giostra E, Majno PE et al. Liver transplantation for Budd Chiari syndrome: a European study on 248 patients from 51 centres. J. Hepatol. 2006; 44: 529-528.
251. Segev DL, Nguyen GC, Locke JE et al. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl. 2007; 13: 1285-1294.
252. Campbell DA Jr, Rolles K, Jamieson N et al. Hepatic transplantation with perioperative and long-term anticoagulation as treatment for Budd-Chiari syndrome. Surg. Gynecol. Obstet. 1988; 166: 511-518.
253. Casella JF, Bontempo FA, Markel H et al. Successful treatment of homozygous protein C deficiency by hepatic transplantation. Lancet 1988; i: 435-438.
254. Zajko AB, Claus D, Clapuyt P et al. Obstruction to hepatic venous drainage after liver transplantation: treatment with balloon angioplasty. Radiology 1989; 170: 763-765.
255. Van Lingen R, Warshow U, Dalton HR, Hussaini SH. Jaundice as a presentation of heart failure. J. Soc. Med. 2005; 98: 357-359.
256. Shibuya A, Unuma T, Sugimoto M et al. Diffuse hepatic calcification as a sequelae to shock liver. Gastroenterology 1985; 89: 196-201.
257. Berger ML, Reynolds RC, Hagler HK et al. Anoxic hepatocyte injury: role of reversible changes in elemental content and distribution. Hepatology 1989; 9: 219-228.
258. Motoyama S, Minamiya Y, Saito S et al. Hydrogen peroxide derived from hepatocytes induces sinusoidal cell apoptosis in perfused hypoxic rat liver. Gastroenterology 1998; 114: 153-163.
259. Weisiger RA. Oxygen radicals and ischemic tissue injury. Gastroenterology 1986; 90: 494-496.
260. Ma TT, Ischiropoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 1995; 108: 463-469.
261. Henrion J, Schapira M, Luwaert R et al. Hypoxic hepatitis. Clinical and haemodynamic study in 142 consecutive cases. Medicine 2003; 82: 392-406.
262. Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am. J. Gastroenterol. 1992; 87: 831-836.
263. Kamiyama T, Miyakawa H, Tajiri K. Ischemic hepatitis in cirrhosis. Clinical features and prognostic implications. J. Clin. Gastroenterol. 1996; 22: 126-130.
264. Mathurin P, Durand F, Ganne N et al. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995; 109: 1682-1684.
265. Hickman PE, Potter JM. Mortality associated with ischaemic hepatitis. Aust. NZ J. Med. 1990; 20: 32-34.
266. Denis C, de Kerguennec C, Bernuau J et al. Acute hypoxic hepatitis("liver shock "): still a frequently overlooked cardiological diagnosis. Eur. J. Heart Failure 2004; 6: 561-565.
267. Nouel O, Henrion J, Bernuau J et al. Fulminant hepatic failure due to transient circulatory failure in patients with chronic heart disease. Dig. Dis. Sci. 1980; 25: 49-52.
268. Nunes G, Blaisdell FW, Margaretten W. Mechanism of hepatic dysfunction following shock and trauma. Arch. Surg. 1970; 100: 646.
269. te Boekhorst T, Urlus M, Doesburg W et al. Etiologic factors of jaundice in severely ill patients: a retrospective study in patients admitted to an intensive care unit with severe trauma or with septic intra-abdominal complications following surgery and without evidence of bile duct obstruction. J. Hepatol. 1988; 7: 111-117.
270. Carrico JC, Meakins JL, Marshall JC et al. Multiple-organ failure syndrome. Arch. Surg. 1986; 121: 196.
271. Batts KP. Ischemic cholangitis. Mayo Clin. Proc. 1998; 73: 380-385.
272. Doctor RB, Dahl RH, Salter KD et al. Reorganization of cholangiocyte membrane domains represents an early event in rat liver ischaemia. Hepatology 1999; 29: 1364-1374.
273. Chu C-M, Chang C-H, Liaw Y-F et al. Jaundice after open heart surgery: a prospective study. Thorax 1984; 39: 52-56.
274. Collins JD, Bassendine MF, Ferner R et al. Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet 1983; i: 1119-1123.
275. Lefkowitch JH, Mendez L. Morphologic features of hepatic injury in cardiac disease and shock. J. Hepatol. 1986; 2: 313-327.
276. Sherlock S. The liver in heart failure; relation of anatomical, functional and circulatory changes. Br. Heart J. 1951; 13: 273-293.
277. Klatt EC, Koss MN, Young TS et al. Hepatic hyaline globules associated with passive congestion. Arch. Pathol. Lab. Med. 1988; 112: 510-544.
278. Shibayama Y. The role of hepatic venous congestion and endotoxaemia in the production of fulminant hepatic failure secondary to congestive heart failure. J. Pathol. 1987; 151: 133-138.
279. Arcidi JM Jr, Moore GM, Hutchins GM. Hepatic morphology in cardiac dysfunction. A clinicopathologic study of 1000 subjects at autopsy. Am. J. Pathol. 1981; 104: 159-166.
280. Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995; 21: 1232-1237.
281. Maisel AS, Atwood JE, Goldberger AL. Hepatojugular reflux: useful in the bedside diagnosis of tricuspid regurgitation. Ann. Intern. Med. 1984; 101: 781-782.
282. Hosoki T, Arisawa J, Marukawa T et al. Portal blood flow in congestive heart failure: pulsed duplex sonographic findings. Radiology 1990; 174: 733-736.
283. Runyon BA. Cardiac ascites: a characterization. J. Clin. Gastroenterol. 1988; 10: 410-412.
284. Moulton JS, Miller BL, Dodd GD III et al. Passive hepatic congestion in heart failure: CT abnormalities. Am. J. Roentgenol. 1988; 151: 939-942.
285. Bohmer T, Kjekshus E, Nitter-Hauge S. Studies on the elevation of bilirubin preoperatively in patients with mitral valve disease. Eur. Heart J. 1994; 15: 1016.
286. Coralli RJ, Crawley IS. Hepatic pulsations in constrictive pericarditis. Am. J. Cardiol. 1986; 58: 370-373.
287. Lowe MD, Harcombe AA, Grace AA et al. Restrictive-constrictive heart failure masquerading as liver disease. Br. Med. J. 1999; 318: 585.